TL1A：TL1A inhibition for inflammatory bowel disease treatment
TL1A inhibition for inflammatory bowel disease treatment
由VSolitano著作·2024·被引用1次—ThepivotalroleofTL1Ainmodulatingimmunepathwayscrucialforinflammatoryboweldisease(IBD)andintestinalfibrosisoffersa ...。其他文章還包含有：「RoleofTL1AinInflammatoryAutoimmuneDiseases」、「Astable」、「TL1Aasatherapeutictargetininflammatoryboweldisease」、「RoleofTL1AanditsreceptorDR3intwomodelsofchronic...」、「TL1AInhibitorsCouldUsherinNewEraforIBDTreatment」
查看更多 離開網站
Role of TL1A in Inflammatory Autoimmune Diseases
https://www.ncbi.nlm.nih.gov
TL1A, also called TNFSF15, is a member of tumor necrosis factor family. It is expressed in different immune cell, such as monocyte, ...
A stable
https://www.nature.com
TL1A (TNFSF15) is a TNF superfamily ligand which can bind the TNFRSF member death receptor 3 (DR3) on T cells and the soluble decoy receptor ...
TL1A as a therapeutic target in inflammatory bowel disease
https://www.tandfonline.com
In conclusion, targeting of TL1A/DR3 signaling may prove an efficient way to ameliorate intestinal and systemic inflammation in patients with IBD. Nevertheless, ...
Role of TL1A and its receptor DR3 in two models of chronic ...
https://www.pnas.org
TL1A is a TNF-like cytokine that binds to the death-domain receptor (DR)3 and provides costimulatory signals to activated lymphocytes.
TL1A Inhibitors Could Usher in New Era for IBD Treatment
https://www.biospace.com
TL1A (tumor necrosis factor-like cytokine 1A) is part of the tumor necrosis factor (TNF) superfamily, a group of cell-signaling molecules that ...